Key Drivers and Catalysts: Unleashing Small-Cap Potential (CERO, EVAX, CTCX, AMST, WETH)

In the ever-evolving world of stock investments, uncovering the hidden gems among small-cap companies can often lead to significant returns. These smaller players in the market are fueled by a unique blend of key drivers and catalysts that can propel them to newfound heights. Today, we are highlighting five small-cap stocks, exploring the factors that unleash their potential and ignite investor interest.

CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) - CERo Therapeutics Holdings, Inc. shares closed last week down 4% at $2.15. The company recently announced the publication of a paper titled “Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia” in Clinical Cancer Research. The paper discusses preclinical studies on CER-1236, the company's lead candidate for Acute Myelogenous Leukemia (AML). Results show CER-1236 targets 83% of leukemic cells and effectively eliminates them. CERo plans to file an Investigational New Drug (IND) application in the first half of 2024. As we await further updates from the company, we'll monitor for a potential resistance break at the $2.25 level or for support to hold at $2.00 with some consolidation.

--

Evaxion Biotech A/S (NASDAQ: EVAX) - Evaxion Biotech A/S saw a slight uptick of over 1% in its company shares at $2.99 by the end of last week's trading session. Recently, the company announced its plans to host a Research & Development (R&D) Day, scheduled for March 19, 2024, from 14:00 - 18:00 CET / 8:00 a.m. - 12:00 a.m. EST. During this event, Evaxion's scientists and bioinformaticians will deliver talks focusing on its AI-Immunology™ platform. The discussions will delve into the platform's capabilities in vaccine target discovery, design, and development, emphasizing its predictive strengths and its potential to address critical medical needs in cancer and infectious diseases. We'll be monitoring the $3.10 resistance level while awaiting updates from the company.

--

Carmell Corporation (NASDAQ: CTCX) - Carmell Corporation's shares closed last week's trading session at $2.45, marking a 6% increase. The company recently announced the completion of product development for their Gold Limited Edition Exclusive (G.L.E.E.) product, slated for commercial launch in March 2024. Furthermore, Carmell is in the advanced stages of developing and testing nine additional skincare products expected to hit the market in Spring and Summer 2024. These skincare offerings are formulated based on the Carmell SecretomeTM, which comprises over 1000 growth factors and proteins extracted from allogeneic human platelets sourced from US FDA-approved tissue banks. The safety and efficacy of this technology have been rigorously tested, exceeding industry standards, including positive outcomes from a prospective, randomized, multi-center Phase 2 human trial. As we await further updates from the company, attention will be on the resistance level around $2.60 or monitoring support levels between $2.00 and $2.05 with consolidation.

--

Amesite Inc. (NASDAQ: AMST) - Amesite Inc. concluded last week's trading session with a 7% increase, closing at $2.26. Earlier this month, the company announced the upcoming launch of its mobile safety application, scheduled for March 31, 2024. This application will feature Active Shooter Preparedness content developed in collaboration with renowned expert Chris Grollnek. It aims to cater to Grollnek's diverse audience, which includes Fortune 100 and 500 companies, small to large corporations, government entities, public organizations, and others. This wide-ranging clientele underscores the universal demand for effective crisis response training across all sectors. We'll monitor for a potential resistance breakout at $2.41 and or watch for the $2.08 level to hold with possible consolidation as we await further company updates.

--

Wetouch Technology Inc. (NASDAQ: WETH) - Wetouch Technology Inc. saw its shares close slightly down by over 2% at $4.44 at the end of last week's trading session. The company recently announced the completion of its underwritten public offering of 2,160,000 shares of common stock at $5.00 per share, generating gross proceeds of $10.8 million. These funds will be allocated towards various purposes including constructing a new factory, purchasing production lines, research and development, repayment of convertible promissory notes, and general corporate needs. Wetouch Technology Inc., a Nevada-based holding company, operates through its wholly-owned subsidiary, focusing on the research, development, manufacturing, sales, and servicing of medium to large-sized projected capacitive touchscreens. Specializing in large-format touchscreens, the company caters to diverse markets such as financial terminals, automotive, POS, gaming, medical, and others. As we await further updates, attention will be on the $4.01 level for support and consolidation.

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTime Penny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.